TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biobact AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
237
|
1,247 |
Financial expenses |
11
|
74
|
70 |
Earnings before taxes |
-122
|
4,591
|
-1,465 |
EBITDA |
-186
|
-1,361
|
-1,288 |
Total assets |
3,634
|
5,345
|
2,505 |
Current assets |
2,217
|
5,345
|
987 |
Current liabilities |
54
|
1,890
|
2,400 |
Equity capital |
3,580
|
3,455
|
-1,171 |
- share capital |
101
|
95
|
98 |
Employees (average) |
1
|
2
|
4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
98.5%
|
64.6%
|
-46.7% |
Turnover per employee |
0
|
118
|
312 |
Profit as a percentage of turnover |
1937.1%
|
-117.5% | |
Return on assets (ROA) |
-3.1%
|
87.3%
|
-55.7% |
Current ratio |
4105.6%
|
282.8%
|
41.1% |
Return on equity (ROE) |
-3.4%
|
132.9%
|
125.1% |
Change turnover |
-254
|
-972
|
-987 |
Change turnover % |
-100%
|
-80%
|
-44% |
Chg. No. of employees |
-1
|
-2
|
-1 |
Chg. No. of employees % |
-50%
![]() |
-50%
|
-20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.